"Blood Biomarker Discovery Offers Hope for Long COVID Detection and Treatment"

TL;DR Summary
A study published in Science has identified a potential biomarker in the complement system of blood serum proteins to detect long Covid, shedding light on the disease and highlighting the key role the immune system plays in its development. The dysregulation of the complement system was found in people with long Covid, potentially explaining symptoms such as fatigue, brain fog, and muscle pain. While the research does not resolve all questions surrounding long Covid, it supports evidence that the immune system plays a key role in the disease and suggests the potential for using complement inhibitors as a treatment.
- Study identifies potential biomarker to detect long Covid EL PAÍS USA
- Study finds blood changes in long-COVID patients University of Minnesota Twin Cities
- Immune dysfunction link to long COVID opens door to therapies FierceBiotech
- Long COVID Signatures Found in Huge Analysis of Blood Proteins Scientific American
- Scientists are finding signals of long covid in blood. They could lead to new treatments. MIT Technology Review
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
6 min
vs 7 min read
Condensed
93%
1,370 → 99 words
Want the full story? Read the original article
Read on EL PAÍS USA